• 1_IMG_4168.jpg
  • 3_IMG_4168.jpg

For the german version, please click here.

To download the press release (separate versions in german and english are available), please click here.

For the english version, please click here.

To download the press release (separate versions in german and english are available), please click here.

Berlin, January 14, 2016
Accelero Bioanalytics is now pleased to provide the 2016 GLP certificate from the competent authority.
Please click here to download the 2016 certificate.

To download the press release, please click here.

Berlin, December 17, 2015
Aptahem AB is a biotechnology company based in Sweden which develops a group of patented RNA aptamers. Aptahem´s lead compound APTA-1 is currently being characterized in their preclinical programs.

For the german version, please click here.

To download the press release (separate versions in german and english are available),
please click here.

The Accelero Team is now pleased to announce the official approval for it´s test facility branch to handle and analyze human infectious pathogens. The written permission to grow and handle microbes like Staphylococcus aureus has been received on 11-MAY-2015, and allows Accelero´s lab team to work on projects in compliance with the German Law on the Prevention and Control of Infectious Diseases (IfSG, Infektionsschutzgesetz).

The permission was granted by the Gesundheitsamt Treptow-Köpenick according to § 49 IfSG, and is valid for safety level S2 projects.

The Accelero Team is now proud to provide a 128-bit encryption of all electronic correspondence like emails, and its attachments.

The open source PGP (pretty good privacy) data encryption algorithm is selected to protect all electronical data exchanged with our clients in the course of confidential projects. File attachments like study plans, study reports, intermediate bioanalysis results, etc can also be encrypted, and therefore are only open to recipients who have the personal key of the sender.

If you are interested to learn more on how we respect our customer´s confidentiality needs, please do not hesitate to contact us at any time.

Private investor meets entrepeneur - see the video at Zencap´s blog (in german), or directly on Youtube (in german).

 

In 2015 Accelero Bioanalytics team members will attend to events which will complete our expert knowledge. Get in touch with us to arrange a handshake appointment.

More that 52 private investors believe that Accelero Bioanalytics´ competent team has fantastic development potential ...

Accelero Bioanalytics GmbH sets the course for continued sustainable growth. The small startup team is now proud to notice an extreme positive feedback from potential investors for its business model. Accelero will close the current commercial year 2014 also with an annual profit, the third year in a row since the company was kicked off in 2011.